quick quotes

“These cases have largely been reported about two weeks after vaccination and mostly in males, many aged 50 years and older.”

The CDC on a new warning by the FDA about a rare side effect related to the Johnson & Johnson COVID-19 vaccine.

Published on

Modified on

    • The side effect is Guillain-Barré Syndrome (GBS) - a condition that can sometimes arise after a viral infection, illness or a vaccine.
    • Guillain-Barré Syndrome (GBS) = “a rare disorder in which your body’s immune system attacks your nerves. Weakness and tingling in your extremities are usually the first symptoms. These sensations can quickly spread, eventually paralyzing your whole body." Mayo Clinic
    • Early indications show that although rare, this condition occurs at a slightly higher rate in those who received the Johnson & Johnson COVID-19 vaccine than in the general population.
    • 100 people reportedly experienced this side effect; 95 were in serious condition requiring hospitalization & one person died.
    • Nearly 13 million Johnson & Johnson COVID-19 vaccine doses have been administered in the U.S. so far.
    • Why This Matters: Although health officials say the benefit of this vaccine outweighs the risk, this is the second serious side effect that has garnered headlines about the one-dose, easy-to-transport Johnson & Johnson COVID-19 vaccine. A rare blood-clotting reaction surfaced (mainly in women) after receiving the vaccine, temporarily halting its administration for further investigation.

    Here’s a good read on the topic: The FDA issued a warning about a rare paralyzing syndrome linked to Johnson & Johnson’s coronavirus vaccine